Literature DB >> 12142378

Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementary transcribed genes in breast cancer lymph nodes.

Barbara K Zehentner1, Davin C Dillon, Yuqiu Jiang, Jiangchun Xu, Angela Bennington, David A Molesh, XinQun Zhang, Steven G Reed, David Persing, Raymond L Houghton.   

Abstract

BACKGROUND: Mammaglobin mRNA expression is found in 70-80% of primary and metastatic breast tumor biopsies. The potential breast tumor markers B305D, B726P, and gamma-aminobutyrate type A receptor pi subunit (GABApi) complement the expression of mammaglobin. Collectively the expression profile of these four genes could be used as a diagnostic and prognostic indicator for breast cancer.
METHODS: A multigene reverse transcription-PCR (RT-PCR) assay was established to detect the expression of mammaglobin, GABApi, B305D, and B726P simultaneously. Specific primers and TaqMan probes were used to analyze combined mRNA expression profiles in primary breast tumors and metastatic lymph node specimens.
RESULTS: The multigene RT-PCR assay detected substantial expression signals in 27 of 27 primary tumor and 50 of 50 metastatic breast lymph node samples. Specificity studies demonstrated no significant expression signal in 27 non-breast cancer lymph nodes, in 22 various healthy tissue samples, or in 14 colon tumor samples.
CONCLUSION: The novel RT-PCR-based assay described here provides a sensitive detection system for disseminated breast tumor cells in lymph nodes. In addition, this multigene assay could also be used to test peripheral blood and bone marrow samples.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12142378      PMCID: PMC1482782     

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  26 in total

Review 1.  State-of-the-art lymph node staging for breast cancer in the year 2000.

Authors:  P Whitworth; K M McMasters; L Tafra; M J Edwards
Journal:  Am J Surg       Date:  2000-10       Impact factor: 2.565

Review 2.  Axillary staging of breast cancer and the sentinel node.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

Review 3.  Detection and clinical relevance of micrometastatic cancer cells.

Authors:  K Pantel; M von Knebel Doeberitz
Journal:  Curr Opin Oncol       Date:  2000-01       Impact factor: 3.645

Review 4.  Detection of minimal residual disease in patients with cancer: a review of techniques, clinical implications, and emerging therapeutic consequences.

Authors:  W J Köstler; T Brodowicz; M Hejna; C Wiltschke; C C Zielinski
Journal:  Cancer Detect Prev       Date:  2000

5.  All human genes of the uteroglobin family are localized on chromosome 11q12.2 and form a dense cluster.

Authors:  J Ni; M Kalff-Suske; R Gentz; J Schageman; M Beato; J Klug
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 6.  Can axillary dissection be avoided by improved molecular biological diagnosis?

Authors:  T Lindahl; G Engel; J Ahlgren; S Klaar; J Bjöhle; H Lindman; J Andersson; E von Schoultz; J Bergh
Journal:  Acta Oncol       Date:  2000       Impact factor: 4.089

Review 7.  Axillary lymph node dissection in breast cancer--current status and controversies, alternative strategies and future perspectives.

Authors:  G H Sakorafas; A G Tsiotou; B M Balsiger
Journal:  Acta Oncol       Date:  2000       Impact factor: 4.089

Review 8.  RT-PCR-based detection of occult disseminated tumor cells in peripheral blood and bone marrow of patients with solid tumors. An overview.

Authors:  A Zippelius; K Pantel
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

9.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

10.  Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients.

Authors:  M Ooka; I Sakita; Y Fujiwara; Y Tamaki; H Yamamoto; T Aihara; M Miyazaki; M Kadota; N Masuda; Y Sugita; K Iwao; M Monden
Journal:  Oncol Rep       Date:  2000 May-Jun       Impact factor: 3.906

View more
  12 in total

1.  Detection of circulating tumor cells in peripheral blood of breast cancer patients during or after therapy using a multigene real-time RT-PCR assay.

Authors:  Barbara K Zehentner; Heather Secrist; Dawn C Hayes; Xinqun Zhang; Richard C Ostenson; Steven Loop; Gary Goodman; Raymond L Houghton; David H Persing
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

2.  Microarray expression profiling of dysregulated long non-coding RNAs in triple-negative breast cancer.

Authors:  Chen Chen; Zhilu Li; Yuan Yang; Tingxiu Xiang; Weihong Song; Shengchun Liu
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

3.  Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis.

Authors:  John Backus; Todd Laughlin; Yixin Wang; Robert Belly; Robert White; Jon Baden; C Justus Min; Ann Mannie; Lorraine Tafra; David Atkins; Kathryn M Verbanac
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

4.  An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes.

Authors:  S Abdul-Rasool; S H Kidson; E Panieri; D Dent; K Pillay; G S Hanekom
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

5.  Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription-PCR assay and sandwich ELISA.

Authors:  Barbara K Zehentner; David H Persing; Amadou Deme; Papa Toure; Stephen E Hawes; Lisa Brooks; Qinghua Feng; Dawn C Hayes; Cathy W Critichlow; Raymond L Houghton; Nancy B Kiviat
Journal:  Clin Chem       Date:  2004-09-16       Impact factor: 8.327

6.  GABA(A) receptor pi (GABRP) stimulates basal-like breast cancer cell migration through activation of extracellular-regulated kinase 1/2 (ERK1/2).

Authors:  Gina M Sizemore; Steven T Sizemore; Darcie D Seachrist; Ruth A Keri
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

7.  Mammaglobin, a valuable diagnostic marker for metastatic breast carcinoma.

Authors:  Zhiqiang Wang; Betsy Spaulding; Anna Sienko; Yiaoming Liang; Hongbao Li; Gitte Nielsen; Gyung Yub Gong; Jae Y Ro; Qihui Jim Zhai
Journal:  Int J Clin Exp Pathol       Date:  2008-12-01

8.  Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study.

Authors:  William E Gillanders; Kaidi Mikhitarian; Renee Hebert; Patrick D Mauldin; Yuko Palesch; Christian Walters; Marshall M Urist; G Bruce Mann; Gerard Doherty; Virginia M Herrmann; Arnold D Hill; Oleg Eremin; Mohamed El-Sheemy; Richard K Orr; Alvaro A Valle; Michael A Henderson; Robert L Dewitty; Sonia L Sugg; Eric Frykberg; Karen Yeh; Richard M Bell; John S Metcalf; Bruce M Elliott; Thomas Brothers; Jay Robison; Michael Mitas; David J Cole
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

9.  Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.

Authors:  Menelaos Zafrakas; Beate Petschke; Andreas Donner; Florian Fritzsche; Glen Kristiansen; Ruth Knüchel; Edgar Dahl
Journal:  BMC Cancer       Date:  2006-04-09       Impact factor: 4.430

10.  Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers.

Authors:  B Weigelt; P Verduijn; A J Bosma; E J Rutgers; H L Peterse; L J van't Veer
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.